Type 2 Diabetes Case Study: HbA1c Reduced from 10.6% to 6.6% in 3 Months
Opening Summary Mrs Neeta Patil, a 45-year-old homemaker, was diagnosed in December 2025 with poorly controlled type 2 diabetes (HbA1c 10.6%) along with dyslipidemia, on a background of long-standing obesity, hypothyroidism and varicose veins. She also reported knee pain, acidity, sole numbness, unsatisfactory motions, hairfall, breathlessness on exertion and excessive sweating. These symptoms were affecting her day-to-day comfort and activity. She was started on the Madhavbaug CDC SP 2 Care Plan at the Aundh clinic, combining Ayurvedic Panchakarma-based medicines with structured monitoring. Within three months, by March 2026, her HbA1c reduced to 6.6%, her weight reduced from 87.2 kg to 80.9 kg, and her blood pressure normalised and this was achieved without any allopathic diabetes medication during this period. Note: individual results vary. This is a single documented case and should not be read as a guarantee of similar outcomes for every patient. Outcome Patient Mrs Neeta Patil Age / Occupation 45 years, Homemaker Primary diagnosis Type 2 Diabetes Mellitus (Dec 2025) and Dyslipidemia (Dec 2025), with pre-existing obesity, hypothyroidism and varicose veins Main symptoms Acidity, bilateral knee pain, bilateral sole numbness and itching, unsatisfactory motions, left hand palm pain, hairfall, breathlessness on exertion (Grade 2), excessive sweating Care plan Madhavbaug CDC SP 2 Care Plan including Glynoma, BAH, Diapram Kadha, Pittashaman Syrup, Symsa, PSR+H8, at Madhavbaug Clinic, Aundh Duration 3 months (December 2025 – March 2026) Key measured result HbA1c reduced from 10.6% to 6.6%; weight reduced from 87.2 kg to 80.9 kg; BP reduced from 160/100 mmHg to 125/80 mmHg, without allopathic diabetes medication during this period The Patient’s Story Mrs Neeta Patil had been managing hypothyroidism and varicose veins for 16 years and obesity for 6 years before she was newly diagnosed with type 2 diabetes and dyslipidaemia in December 2025. At presentation, she was troubled by recurring acidity, joint pain and disturbed bowel movements that made her daily household routine harder to manage, alongside hairfall and excessive sweating that added to her discomfort. Symptoms and Impact on Daily Life Symptom Since when? Severity / frequency Acidity, chest burning, gases, abdominal distension On/off Not specified Bilateral knee pain 1 month Moderate–severe (++) Bilateral sole numbness 4 days Mild (+) Unsatisfactory motions 1 month Not specified Bilateral sole itching 1 month Mild (+) Left hand palm pain 6 months Mild (+) Hairfall 1 year Moderate–severe (++) Dyspnea on exertion, Grade 2 On/off Mild (+) Reduced exertional capacity Excessive sweating 5 months Moderate–severe (++) Medical History and Care Before Madhavbaug Known case of: Type 2 Diabetes Mellitus (Dec 2025), Dyslipidaemia (Dec 2025), Obesity (6 years), Hypothyroidism (16 years), Varicose veins (16 years) Confirmed diagnosis date: December 2025 (diabetes and dyslipidaemia) Relevant comorbidities: Obesity, hypothyroidism, varicose veins Baseline Diagnostic Findings (December 2025) Parameter Baseline value Reference / target HbA1c 10.6% Below 5.7% (non-diabetic reference) BMI 33.2 23–24 Abdominal Girth 108 cm 90 cm Blood Pressure 160/100 mmHg 110/70 mmHg Personalised Care Plan Care component Details Care plan Madhavbaug CDC SP 2 Care Plan, 3 months (Dec 2025 – Mar 2026). For glycaemic and metabolic parameter improvement Madhavbaug medicines Glynoma, BAH, Diapram Kadha, Pittashaman Syrup, Symsa, and PSR+H8, taken as prescribed Progress and Measured Results Before-and-After Results Parameter Before After Change Weight 87.2 kg 80.9 kg ↓ 6.3 kg (7.2%) BMI 33.2 30.8 ↓ 2.4 (7.2%) Improved, though it remained in the obese range Abdominal Girth 108 cm 100 cm ↓ 8 cm (7.4%) Blood Pressure 160/100 mmHg 125/80 mmHg ↓ 35 mmHg systolic (21.9%), ↓ 20 mmHg diastolic (20%) HbA1c 10.6% 6.6% ↓ 4.0 percentage points (37.7%) Symptom Relief After Treatment Symptom Relief reported Acidity 95% relief Unsatisfactory motions 90% relief Bilateral knee pain 60% relief Bilateral sole numbness 60% relief Excessive sweating 60% relief Dyspnea on exertion, Grade 2 40% relief Left hand palm pain 30% relief Results Narrative Within three months of starting the Madhavbaug CDC SP 2 Care Plan at the Aundh clinic, Mrs Neeta Patil showed measurable improvement across multiple parameters. Her HbA1c reduced from 10.6% to 6.6%, reflecting substantially better glycaemic control, achieved without allopathic diabetes medication during this period. She also lost 6.3 kg in weight, with her abdominal girth reducing by 8 cm, and her blood pressure improved from 160/100 mmHg to 125/80 mmHg. Alongside these measured changes, she reported major relief from acidity (95%) and unsatisfactory motions (90%), with moderate relief from knee pain, sole numbness and sweating. Hairfall and left-hand palm pain showed partial relief. Conclusion Mrs Neeta Patil began this journey with newly diagnosed, poorly controlled type 2 diabetes and dyslipidaemia, layered onto long-standing obesity, hypothyroidism and varicose veins. Over three months on the personalised Madhavbaug CDC SP 2 Care Plan, her most notable verified improvement was her HbA1c falling from 10.6% to 6.6% alongside meaningful reductions in weight, abdominal girth and blood pressure that was achieved without allopathic diabetes medication during this period. Every patient’s diabetes journey is different, and this case is shared to illustrate one documented, doctor-supervised outcome rather than as a promise of similar results for others. If you’re managing type 2 diabetes or a similar combination of conditions, the most useful next step is a personal assessment of your own reports and symptoms. Understand What the Right Care Plan Could Look Like for You Every patient’s condition and response are different. Book an assessment with a Madhavbaug doctor to discuss your reports, symptoms and suitable next steps. Frequently Asked Questions How much did HbA1c reduce in this case, and over what period? HbA1c reduced from 10.6% to 6.6% over 3 months of the Madhavbaug CDC SP 2 Care Plan. Was any allopathic diabetes medication used during this period? The case notes state that this improvement was achieved without allopathic diabetes medication during this period. What tests were used to track progress? Progress was tracked using HbA1c, weight, BMI, abdominal girth and blood pressure. Can these results be expected for every diabetes patient? No. Outcomes vary from person to person depending on individual health status, adherence and other factors. This case describes one patient’s documented,